Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.447EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.180EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.155EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.92EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.145EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.201EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.410EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.3 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.283EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.96EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XATEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used